18F-AlF-FAPi-04 PET/CT Imaging in Patients With Solid Tumor

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 18, 2023

Primary Completion Date

May 31, 2024

Study Completion Date

July 31, 2024

Conditions
Tumor, Solid
Interventions
DRUG

Radiation: 18F-AlF-FAPi-04

Subjects who meet all the inclusion criteria will receive intravenous administration of 18F-AlF-FAPi-04 with a dosage range of 0.1-0.2 mCi/Kg. After administration, PET/CT scans will be performed at three time points: 1h, 2h, and 4h post dose. The subjects will also receive administration of 18F-FDG and undergo PET/CT scans for self-control analysis.

DRUG

Radiation: 18F-FDG

Subjects who meet all the inclusion criteria will receive intravenous administration of 18F-AlF-FAPi-04 with a dosage range of 0.1-0.2 mCi/Kg. After administration, PET/CT scans will be performed at three time points: 1h, 2h, and 4h post dose. The subjects will also receive administration of 18F-FDG and undergo PET/CT scans for self-control analysis.

Trial Locations (1)

Unknown

RECRUITING

Affiliated Hospital of North Sichuan Medical College, Nanchong

All Listed Sponsors
lead

Affiliated Hospital of North Sichuan Medical College

OTHER